USPTO serial 75582112
QTC
Reviewed by CopyMark Law Group
Reg. 2570553Status 710
- Filing date
- Status date
- Registration date
- May 21, 2002
- Examiner
- CARROLL, DORITT
- Law office
- SCANNING ON DEMAND
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with QTC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Slough, Berkshire, SL1 4EF, GB
Slough, Berkshire, SL1 4EF, GB
Slough, Berkshire, SL1 4EF, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Martin P Hoffman
MARTIN P HOFFMAN HOFFMAN WASSON & GITLER PC2361 JEFFERSON DAVIS HWY STE 522ARLINGTON, VA 22202-3876UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in the manufacture of pharmaceutical products; chemical preparations for use in manufacture of pharmaceuticals; microbial and plant extracts used as ingredients in drugs | SECTION 8 - CANCELLED | — |
| 005 | Pharmaceutical and veterinary preparations and substances, namely ointments, creams, gels, impregnated patches, topically applied pharmaceuticals, orally administered preparations namely tablets, capsules, syrups, suspensions, and emulsions for the treatment of human pharmaceutical indications namely cancer, cardiovascular, respiratory, autoimmunity, infectious and neurological diseases; parenteral products, namely solutions, freeze dried preparations and emulsions, for injection or infusion for the treatment of human pharmaceutical indications, namely cancer, cardiovascular, respiratory, autoimmunity, infectious and neurological diseases; aerosols, powders and products to be inhaled for the treatment of human pharmaceutical indications, namely cancer, cardiovascular, respiratory autoimmunity, infectious and neurological diseases; suppositories, pessaries, products using lipid encapsulation for the treatment of human pharmaceutical indications, namely cancer, cardiovascular, respiratory, autoimmunity, infectious and neurological diseases; combinations with other molecules to increase the bioavailability of non-systematically available drugs, namely antibiotics and anticancers; fungicides for agricultural and domestic use; herbicides for agricultural and domestic use; pesticides for agricultural and domestic use | SECTION 8 - CANCELLED | — |
| 042 | Research and development services for others for new chemical, biochemical and biological products; research and development services for others for the improvement of existing products; chemical consultation, namely the development of assay systems in the development of libraries of natural products and chemicals; chemicals; chemical analysis of natural products exemplified by microbial and plant extracts; research services relating to the development of new drugs; provision or lending of microbials, plant extracts and chemical samples; providing databases containing information regarding a library of compounds produced as a result of screening purified chemical entities derived from microbes and plants; consultancy in the field of the screening and analysis of data resulting from the testing of natural products libraries; technical research in the field of the discovery and development of pharmaceutical products using a library of compounds produced as a result of biologically screening purified chemical entities derived from microbes and plants; testing of purified chemical entities derived from microbes and plants | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Xenova LTD.
- Other trademarks owned by Xenova LTD.
- Other trademarks owned by Xenova LTD.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named QTC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 28, 2009 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Aug 24, 2007 | CFIT | CASE FILE IN TICRS | — |
| May 21, 2002 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 30, 2002 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Mar 30, 2002 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Feb 19, 2002 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 27, 2001 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 7, 2001 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 26, 2001 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 26, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 29, 2001 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 19, 2001 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 1, 2000 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 3, 2000 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 2, 1999 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 23, 1999 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 25, 1999 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 16, 1999 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |